Novogene, a leading provider of genomics and bioinformatics services, has taken delivery of two state-of-the-art PacBio Revio sequencers to its new laboratory at the Innovation and Start-up Center for Biotechnology (IZB) in Munich. This expansion marks a pivotal moment in the company’s mission to provide comprehensive genomic solutions to researchers across Europe. Long-read sequencing technology has emerged as a transformative tool in genomics, enabling scientists to unravel complex genomic structures, identify structural variants, and explore regions previously inaccessible with short-read sequencing methods. Novogene’s investment in two PacBio Revio sequencers will equip European researchers with cutting-edge technologies, supporting their study into the intricacies of the genome. This latest development highlights Novogene’s commitment to being a trusted genomics partner for European scientists. Stay tuned for service launch updates!